Skip to main content
. Author manuscript; available in PMC: 2014 Oct 21.
Published in final edited form as: Mol Genet Metab. 2008 Aug 3;95(0):39–45. doi: 10.1016/j.ymgme.2008.06.002

Table 2.

Laboratory Values and Genetic Mutations

Case Acylcarnitine C4 Labs Normal < 1.06 μmol/L Ethylmalonic Acid Labs Normal = .5–20.20 μg/mg creatinine Genotype Allele 1 Genotype Allele 2
Newborn Screened
Case 1 2.96 NBS
2.51 Repeat
247.00
265.00
505A>C
625G>A
505A>C
625G>A
Case 2 2.0 NBS
1.77 Repeat
2.04 at follow-up
330.93 319C>T 319C>T
Case 3 2.83 NBS
3.14 Repeat
67.84 529T>C 529T>C
Case 4 2.6 NBS
2.33 Repeat
249.17 319C>T 319C>T
Case 5 3.7 NBS
1.04 Repeat
41.25
41.60
625G>A 625G>A
Case 6 2.11 NBS
1.93 Repeat
1.72 at follow-up
Elevated (NA) 319C>T 991G>A
Case 7 5.16 NBS
2.38 Repeat
182.00
372.00
529T>C 988C>T
Case 8 2.86 NBS
.96 Repeat
118.00 625G>A 988C>T
Identified because of Clinical Symptoms
Case 9 Normal NBS
.35 at follow-up
33.29 625G>A 625G>A
Case 10 No NBS in state
.74 Initial at 17 months
.91 at follow-up
1.68 at follow-up
38.98 625G>A 625G>A
Case 11 Normal NBS Normal 625G>A 511C>T
Case 12 No NBS in state
5.11 at follow-up
30.00 625G>A 511C>T
Case 13 No NBS in state
2.44 at follow-up
1.38 at follow-up
24.28 625G>A
136C>T
625G>A
Case 14 Normal NBS
1.09 at follow-up
21.96
54.42
625G>A 625G>A
*

NBS = Newborn Screening